If you’d told me a few years ago that I’d be singing the praises of CBD, I probably would have laughed. Like a lot of people, ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

Turns out there are plenty of health-focused reasons for adding some extra spice to your food, says new research.

As we observe Endometriosis Awareness Month in March, let us take a look at 7 biotech companies advancing promising ...

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment.

Dubai-based Malini Nair’s 10-year-old is annoyed. His siblings devour spicy foods without a blink, but he struggles with ...

Pooled data analysis shows that pain relief is only marginally better than placebo. A pooled analysis of existing research, ...

Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Only 1 in 10 nonsurgical treatments for low back pain are more effective placebo, a review of 56 different treatments and ...

In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...

Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the ...